The hemostatic products currently available on the market have several limitations, including high cost, delayed onset of action and adverse events such as burns.
The proposed invention describes a process for obtaining nanozeolites which may be used as a hemostatic agent. These compounds, in addition to accelerating coagulation without the side effect of burns, also generate more efficient applications than the products currently found on the market due to the nanometric size of the particles.
The invention describes a process for obtaining a compound having the potential for use as a hemostatic coagulating agent. This can be used in emergency rooms in hospitals, dental and veterinary offices, as well as emergency mobile service (Samu).
Agência Unesp de Inovação
Tel: +55 11 5627.0696
[PodInovar] Parceria com AUIN é fundamental no desenvolvimento de eventos de tecnologia e empreendedorismo, destaca coordenadora do IBIT
Acesse aqui os registros de patentes da UNESP
Portal do ex-aluno